CoMind’s mission is to develop a new generation of technologies to monitor, modulate, and interface with the human brain. In doing so, we will revolutionise patient care, catalyse neuroscientific advancement, and change how humans interact with technology for the better.

CoMind has raised more than $15 million to date to pursue this mission. Our current focus is on the development of a new form of neural sensing. CoMind’s technology will provide doctors with a huge range of critical neurophysiological signals, many of which are inaccessible today, in a single, simple, non-invasive measurement at the patient’s bedside.